Smart Home Technology

AI isn’t just designing buildings — it’s transforming real estate at scale. Would you agree? Imagine walking through your dream apartment before it exists. Seeing every corner staged perfectly, every detail optimized, every design choice made smarter — all before a single brick is laid. AI is now helping developers: ✨ Generate 10+ floor plan options in minutes ✨ Stage apartments virtually — saving up to $20,000 per unit on furniture and photography ✨ Create cinematic walkthroughs — boosting engagement by 3x ✨ Predict market demand and ROI — increasing project success rates by 25% Here’s how AI is impacting homes and properties: 🏠 Average apartment can be fully designed and visualized in 48 hours instead of weeks 📈 Virtual staging increases online listings click-through rates by 60% 💰 Developers report 10–15% faster sales cycles with AI-powered marketing 🏡 AI can optimize space — up to 12% more usable area per floor plan 🌎 Predictive analytics can choose locations with 30% higher rental yield potential The future of real estate isn’t just about buildings — it’s about experiences, speed, and intelligence. If you’re in property, architecture, or design, the question isn’t whether AI will change your work… it’s how fast you’ll adapt. #AI #PropTech #RealEstateInnovation #FutureOfDesign #Architecture #DigitalTransformation #SmartHomes

⌚️ Wearables Just Got Political — and That Changes Everything The White House just made its boldest move yet toward proactive healthcare: 📲 A nationwide initiative to integrate wearables into public health 📈 Every American encouraged to track HRV, glucose, sleep, stress & more 💡 The goal? Shift from treatment → prevention 𝗪𝗲𝗮𝗿𝗮𝗯𝗹𝗲𝘀 𝗮𝘀 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗶𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲. Let that sink in. 🩺 𝟔𝟎% 𝐨𝐟 𝐀𝐦𝐞𝐫𝐢𝐜𝐚𝐧𝐬 suffer from one or more chronic illnesses 💸 𝟗𝟎% 𝐨𝐟 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐬𝐩𝐞𝐧𝐝𝐢𝐧𝐠 goes to preventable conditions — but most people wait for a diagnosis to start caring ⌚️ 𝟏 𝐢𝐧 𝟑 𝐚𝐦𝐞𝐫𝐢𝐜𝐚𝐧𝐬 already wear a health tracker So whats the plan? The U.S. government launched the Health Tech Ecosystem Initiative — bringing together Apple, Google, Oura, OpenAI, Microsoft, Cleveland Clinic, and many others to: • Build interoperable systems • Enable real-time access • Put users in control of their health data (hope so) It’s a massive shift. But also: a massive opportunity. Here’s the catch: Data without context is just noise. We don’t just need more devices. We need systems that understand... 🧠 Your physiology 🍽️ Your nutrition 💤 Your sleep 🏙️ Your environment 🧬 Your biomarkers This isn’t about passive tracking. It’s about real-time intelligence — embedded into everyday life. For decades, we treated illness only once it showed up. Now, for the first time, we’re building systems that could act before the crisis. 📲 The US government isn’t just endorsing wearables. It’s acknowledging that real-time insight is the next layer of healthcare infrastructure. But let’s be clear: • Without interoperability → it’s fragmented • Without trust → it’s surveillance • Without coaching → it’s just noise The real breakthrough? 🔁 Contextualized intelligence 🧠 Interpreted by AI 🌍 Informed by your environment 🎯 Delivered with purpose 👥 Empowering humans & professionals The future of healthcare? It’s proactive. It’s predictive. It’s hyper-personalized. And for the first time ever — It might just scale. This won’t happen overnight. Some countries will move faster, others will regulate longer. Trust, governance, and ethical data use will define the path forward. But the direction is clear. The question isn’t if this shift will happen… it’s how we will shape it. And what’s Europe’s response to this shift? Are we ready to reimagine health tech as a collective priority too?

We almost deployed this system at IKEA. Would have tracked everything: customer flow, queue times, employee movement, table turnover at the restaurant. Cost killed it. But watching CCTV footage from a cafe using this tech yesterday made me realize we dodged something bigger. Here's what these systems DO brilliantly: - Optimize queue flow (cut wait times) - Map customer movement (spot confusing layouts, find hot spots) - Identify bottlenecks (process problems, not people) - Smart staffing decisions (based on real patterns) Here's where it goes WRONG: - The second you measure "coffees per hour" per barista, you've shifted from operational intelligence to surveillance culture. Those speed metrics miss everything that matters: The regular who needs 30 seconds of conversation. Complex drinks that take time. Training moments with new staff. The human interactions that BUILD loyalty. Research shows this pattern clearly: when a measure becomes a target, it ceases to be a good measure (Goodhart's Law). Use these systems for operational intelligence. Track patterns. Optimize flows. Improve experience. But tie it to individual KPIs? You just told your team speed matters more than the moment. And moments build brands. What's your take - where's the line between smart operations and surveillance?

If you’re in real estate and still seeing AI as “fancy tech,” you’re already behind. In the last 90 days, I’ve seen developers use AI not for gimmicks—but for real business breakthroughs: • A mid-sized firm in Pune increased site visit conversions by 32% just by plugging conversational AI into their WhatsApp follow-ups. • A luxury builder in Gurgaon used computer vision models to scan years of walkthrough footage and redesign floorplans based on where people paused longest. • A commercial real estate platform in Bangalore cut property matching time from 3 hours to 3 minutes using a GPT-powered property description parser that aligns client briefs with listings dynamically. And here’s the kicker—none of these firms have an in-house data science team. They’re using off-the-shelf APIs, open-source models, and freelance AI integrators. The insight? AI in real estate isn’t about building tech. It’s about asking the right business question: “Where am I losing speed, trust, or money because of human lag?” That’s where AI fits. So whether you’re a broker, developer, fund manager, or platform founder—start small: • Use AI to write better listing descriptions. • Use AI to summarise legal docs. • Use AI to simulate cash flow risk across market cycles. You don’t need to invent AI for real estate. You need to apply it like a practitioner. Because in 2025, real estate isn’t going to be about who builds bigger. It’ll be about who builds smarter—and faster. #realestateindia #AI #proptech #gpt #smartdevelopment #founderinsights #technologyinrealestate #salesenablement #realestateinnovation #ashwinderrsingh

Evidence-based medicine must apply to digital health technologies too! No matter how innovative a technology is, medical professionals can only use it in practice if there are peer-reviewed studies and clinical trials proving its efficiency and safety. This is what AliveCor has been doing with its smartphone-connected ECG. A new study just evaluated the accuracy of the recordings and interpretations of the Kardia 12L device comparing it to standard 12-lead ECG technology. "𝐾𝑎𝑟𝑑𝑖𝑎 𝟣𝟤𝐿 𝑢𝑠𝑒𝑠 𝑎 𝑑𝑒𝑒𝑝 𝑛𝑒𝑢𝑟𝑎𝑙 𝑛𝑒𝑡𝑤𝑜𝑟𝑘 𝑚𝑜𝑑𝑒𝑙, 𝑒𝑥𝑝𝑎𝑛𝑑𝑖𝑛𝑔 𝑒𝑖𝑔ℎ𝑡 𝑙𝑒𝑎𝑑𝑠 𝑖𝑛𝑡𝑜 𝑎 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒 𝟣𝟤-𝑙𝑒𝑎𝑑 𝐸𝐶𝐺. 𝐼𝑛 𝟣𝟧𝟢 𝑝𝑎𝑟𝑡𝑖𝑐𝑖𝑝𝑎𝑛𝑡𝑠, 𝑎𝑙𝑙 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡𝑠 𝑠ℎ𝑜𝑤𝑒𝑑 𝑠𝑡𝑟𝑜𝑛𝑔 𝑐𝑜𝑟𝑟𝑒𝑙𝑎𝑡𝑖𝑜𝑛, 𝑚𝑒𝑎𝑛𝑖𝑛𝑔 𝐾𝑎𝑟𝑑𝑖𝑎’𝑠 𝑒𝑣𝑎𝑙𝑢𝑎𝑡𝑖𝑜𝑛𝑠 𝑎𝑟𝑒 “ℎ𝑖𝑔ℎ𝑙𝑦 𝑠𝑖𝑚𝑖𝑙𝑎𝑟” 𝑡𝑜 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝟣𝟤-𝑙𝑒𝑎𝑑 𝐸𝐶𝐺, 𝑎𝑐𝑐𝑜𝑟𝑑𝑖𝑛𝑔 𝑡𝑜 𝑡ℎ𝑒 𝑠𝑡𝑢𝑑𝑦’𝑠 𝑎𝑏𝑠𝑡𝑟𝑎𝑐𝑡. 𝑇ℎ𝑖𝑠 𝑒𝑛𝑎𝑏𝑙𝑒𝑠 𝑡ℎ𝑒 𝑟𝑎𝑝𝑖𝑑 𝑎𝑐𝑞𝑢𝑖𝑠𝑖𝑡𝑖𝑜𝑛 𝑜𝑓 𝑐𝑜𝑚𝑝𝑙𝑒𝑡𝑒 𝐸𝐶𝐺 𝑖𝑛𝑓𝑜𝑟𝑚𝑎𝑡𝑖𝑜𝑛 𝑖𝑛 𝑐𝑙𝑖𝑛𝑖𝑐𝑎𝑙 𝑝𝑟𝑎𝑐𝑡𝑖𝑐𝑒. 𝐼𝑛𝑣𝑒𝑠𝑡𝑖𝑔𝑎𝑡𝑜𝑟𝑠 𝑐𝑜𝑛𝑐𝑙𝑢𝑑𝑒𝑑 𝑡ℎ𝑎𝑡 𝐾𝑎𝑟𝑑𝑖𝑎𝑀𝑜𝑏𝑖𝑙𝑒 𝟨𝐿-𝑑𝑒𝑟𝑖𝑣𝑒𝑑 𝑟𝑒𝑐𝑜𝑟𝑑𝑖𝑛𝑔𝑠 𝑠𝑖𝑔𝑛𝑖𝑓𝑖𝑐𝑎𝑛𝑡𝑙𝑦 𝑖𝑚𝑝𝑟𝑜𝑣𝑒 𝑡ℎ𝑒 𝑑𝑒𝑡𝑒𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝑎𝑟𝑟ℎ𝑦𝑡ℎ𝑚𝑖𝑎𝑠 𝑖𝑛 𝑠𝑦𝑚𝑝𝑡𝑜𝑚𝑎𝑡𝑖𝑐 𝑝𝑎𝑡𝑖𝑒𝑛𝑡𝑠 𝑐𝑜𝑚𝑝𝑎𝑟𝑒𝑑 𝑡𝑜 𝐻𝑜𝑙𝑡𝑒𝑟 𝑚𝑜𝑛𝑖𝑡𝑜𝑟𝑖𝑛𝑔." Excellent progress which will allow smartphone-connected ECGs to become widely available in medicine.

The data is screaming a failure of leadership: You cannot buy better patient outcomes. Industry has treated digital health like an IT project, not a human transformation. And the result is a $100 Billion to $300 Billion annual non-adherence problem in the U.S. alone. Stop buying tech that adds friction. Start investing in invisible empathy. The real transformation doesn't happen when a new server racks up. It happens when a well-designed tool hands a physician more time to look a patient in the eye. This is the non-negotiable ROI of smart health technology: Time returned to the caregiver. If your solution demands the human workflow adapt to the software (EHRs, I'm looking at you), you've lost. You have introduced the Curse of Intelligence, prioritizing complexity over care. Connected Care demands we reverse this. The mandate is simple for Founders and Executives: Design for the "From Home, Back to Home" Loop. The critical disconnect happens after discharge. The patient's core human need shifts to continuous reinforcement and accountability. The Connected Care model solves this. This is where technology must be a seamless enabler, not a distraction: Wrong Focus: Generic medication reminders and confusing portal dashboards. Right Focus: AI-powered nudges, triggered by integrated biometrics (IoT), that translate complex data into a simple, real-time message of support. When a virtual monitoring system detects a deviation (missed exercise, sudden weight gain), it must deliver personalized, empathetic coaching. This scales the vital function of an expensive human health coach. The formula is simple: Connected Care + Personalization = Adherence. It is estimated that highly personalized digital messaging can increase adherence rates by almost 18%. That's not a technical win; that's a human win scaled by technology. The technology you can't see working is often the one generating the highest value. True Connected Care is felt, not seen. #HealthTech #DigitalHealth #HealthcareStrategy #HealthIT #ConnectedCare

🚀 $40B+ in R&D… but what are MedTech giants actually building? Everyone talks about revenue. Smart players watch innovation direction. Here’s what the top MedTech companies are really pushing right now: 🔬 Johnson & Johnson → Surgical robotics (Ottava platform) → Minimally invasive surgery → Digital surgery ecosystems 👉 Surgery is becoming data-driven, not just skill-driven 🧪 Roche → Advanced diagnostics → Personalized medicine → AI-powered lab systems 👉 The future is treatment tailored to one patient, not millions 🩺 Abbott Laboratories → Continuous glucose monitoring (FreeStyle Libre) → Rapid diagnostics → Wearable biosensors 👉 Healthcare is moving from hospitals → to everyday life ❤️ Medtronic → Implantable devices → AI-assisted surgery → Remote patient monitoring 👉 Chronic disease management = long-term tech ecosystem 🧠 Siemens Healthineers → AI imaging (MRI, CT) → Digital twins in healthcare → Advanced oncology systems 👉 Imaging is shifting from “pictures” → to predictive insights 🖥 Philips → Connected care platforms → Telehealth → ICU data integration 👉 Hospitals are becoming software platforms ⚙️ Boston Scientific → Minimally invasive devices → Cardiovascular innovations → Neuromodulation 👉 Less invasive = faster recovery = massive demand 🏥 Stryker → Smart surgical tools → Orthopedic robotics → AR in surgery 👉 Surgeons will operate with augmented vision 💉 Becton Dickinson → Smart drug delivery → Automation in labs → Infection prevention tech 👉 Efficiency in healthcare = billions saved 📡 GE HealthCare → AI diagnostics → Imaging + cloud integration → Precision care platforms 👉 Data is becoming the core medical asset 💡 Big picture We’re not just seeing new products. We’re seeing 3 massive shifts: Healthcare → predictive, not reactive Devices → connected ecosystems Hospitals → distributed (home + remote care)

𝗧𝗵𝗲 𝗙𝗗𝗔 𝗷𝘂𝘀𝘁 𝗰𝗿𝗮𝗰𝗸𝗲𝗱 𝗼𝗽𝗲𝗻 𝘁𝗵𝗲 𝘄𝗲𝗹𝗹𝗻𝗲𝘀𝘀 𝗹𝗮𝗻𝗲 𝘄𝗶𝗱𝗲𝗿 𝘁𝗵𝗮𝗻 𝗺𝗼𝘀𝘁 𝗽𝗲𝗼𝗽𝗹𝗲 𝗿𝗲𝗮𝗹𝗶𝘇𝗲. As of this month, consumer devices can now surface physiological metrics like blood pressure and glucose estimates, as long as they stay wellness-only (no diagnosis, no treatment claims). Last year, WHOOP got a warning letter for launching blood pressure tracking without authorization. This new guidance finally draws clearer lines. 𝗕𝘂𝘁 𝗵𝗲𝗿𝗲'𝘀 𝘄𝗵𝗮𝘁 𝗰𝗮𝘂𝗴𝗵𝘁 𝗺𝘆 𝗲𝘆𝗲: This isn't just about wearables. The guidance covers any non-invasive wellness tool – including ones that analyze biological samples like stool, saliva, or blood – as long as they're validated and stay in the wellness lane. 𝗪𝗵𝘆 𝘁𝗵𝗶𝘀 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: Your ŌURA ring tells you your HRV tanked and you slept terribly. But it can't tell you why. 𝗧𝗵𝗮𝘁'𝘀 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗳𝗿𝗼𝗻𝘁𝗶𝗲𝗿. Connecting wearable signals to deeper biomarkers (gut microbiome, metabolic markers, hormones) to help people understand the root drivers behind what their devices are showing them. Wearables capture the signal. Biomarkers could explain the source. 𝗧𝗵𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝘁𝗵𝗮𝘁 𝘄𝗶𝗻 𝘄𝗼𝗻'𝘁 𝗷𝘂𝘀𝘁 𝗰𝗼𝗹𝗹𝗲𝗰𝘁 𝗺𝗼𝗿𝗲 𝗱𝗮𝘁𝗮 𝗽𝗼𝗶𝗻𝘁𝘀. They'll figure out how to connect the dots across systems to give people actionable insights, not just more numbers. More metrics ≠ better health outcomes. 𝗠𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗶𝗻𝘁𝗲𝗿𝗽𝗿𝗲𝘁𝗮𝘁𝗶𝗼𝗻 𝗱𝗼𝗲𝘀. What wellness tools are you watching in 2026? Official FDA announcement here: https://lnkd.in/gtD6kcvQ

“We thought the screens would just work” 🤦♂️ We hear this a lot from companies rolling out digital signage for the first time. They assume that when something goes wrong, someone on the ground will fix it. Or it’ll magically sort itself out. Newsflash: It won’t. Remote Device Management (RDM) isn’t a nice-to-have. It’s the difference between a 2-minute fix & an $800 site visit. That’s the real cost for sending a technician onsite. Just to push a cable back in or switch an input source. And it’s even more complicated in high-security environments like airports. Meanwhile, the screen stays dark. Your comms stay silent. And your team stays frustrated. The good news is RDM costs next to nothing in comparison. And your IT team will thank you. So when you’re building your digital signage network, don't forget to factor in RDM from the start. Trust me on this one. #DigitalSignage #RemoteDeviceManagement #EnterpriseIT #InternalComms #ScreenCloud

The FDA just updated its lists of medical devices that incorporate digital health technologies, now including sensor-based digital health technologies (sDHTs) for the first time. 🔗 https://lnkd.in/d3wg_6rm While AI/ML-enabled and AR/VR devices have been tracked for some time, the addition of sDHTs is exciting: ✅ It signals maturity. Reimbursement pathways for remote patient monitoring (RPM) and remote therapeutic monitoring (RTM) are now well established and delivering real value, driving a double bottom line for care providers and the patients they serve. ✅ It reinforces regulatory clarity. Despite ongoing hesitation in life sciences to embrace digital endpoints, the FDA continues to demonstrate its ability to evaluate these tools and its commitment to supporting high-quality innovation in the digital era of medicine. We had a little fun at the Digital Medicine Society (DiMe) this afternoon doing a quick cut of the data across AI/ML, AR/VR, and sDHTs: 📈 AI/ML dominates the landscape, with explosive growth starting around 2015 🧠 Neurology is a leading therapeutic area across all three categories 🫀 Cardiovascular dominates sDHT use cases and is also well represented in AI/ML and AR/VR 🩻 Radiology leads in AI/ML and AR/VR, but is absent in sDHTs 🧪 And spoiler: CGMs show up under clinical chemistry 😉 We’ll share more next week as we sit with the data a bit longer. In the meantime, kudos to FDA's Digital Health Center of Excellence for making this information public. It is only thanks to these newly released data that we can start to see the full picture. The landscape of medical devices incorporating digital health technologies is maturing quickly. It is increasingly capable of meeting the needs of our healthcare system and the patients we serve, and rising to the ambitions of a new administration committed to fully realizing the promise of digital health. #DigitalHealth #FDA #sDHT #RemoteMonitoring #RPM #RTM #DigitalEndpoints #HealthAI #HealthTech #CGM #RegulatoryScience #Innovation #ARVR #MedicalDevices